Iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide)
C72H51IrN6 — CID 139253791
Data last refreshed: (MolForge compound catalog, from PubChem)
About Iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide)
Iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide) (PubChem CID 139253791) has the molecular formula C72H51IrN6 and a molecular weight of 1192.46 g/mol. Its IUPAC name is iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide).
Molecular Properties
| Compound Name | Iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide) |
|---|---|
| PubChem CID | 139253791 |
| Molecular Formula | C72H51IrN6 |
| Molecular Weight | 1192.46 g/mol |
| Exact Mass | 1192.38 |
| IUPAC Name | iridium(3+);tris(9-(4-methylphenyl)-3-pyridin-2-yl-2H-carbazol-2-ide) |
| SMILES | Cc1ccc(-n2c3c[c-]c(-c4ccccn4)cc3c3ccccc32)cc1.Cc1ccc(-n2c3c[c-]c(-c4ccccn4)cc3c3ccccc32)cc1.Cc1ccc(-n2c3c[c-]c(-c4ccccn4)cc3c3ccccc32)cc1.[Ir+3] |
| InChI | InChI=1S/3C24H17N2.Ir/c3*1-17-9-12-19(13-10-17)26-23-8-3-2-6-20(23)21-16-18(11-14-24(21)26)22-7-4-5-15-25-22;/h3*2-10,12-16H,1H3;/q3*-1;+3 |
| InChIKey | NOHADYMKADFDAH-UHFFFAOYSA-N |
| XLogP | 17.86 |
| TPSA | 53.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 79 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1192.46 |
| LogP ≤ 5 | 17.86 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139253791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.